title: Preventing varicella-zoster disease.
abstract: Varicella-zoster virus (VZV), the cause of chickenpox and shingles, is a pathogen in retreat following the introduction of mass vaccination in the United States in 1995. The live attenuated Oka vaccine, which is safe and immunogenic, gives good protection against both varicella and zoster in the short to medium term. It has undoubtedly been highly effective to date in reducing all forms of varicella, especially severe disease. However, the huge pool of latent wild-type virus in the population represents a continuing threat. Both the biology and the epidemiology of VZV disease suggest that new vaccination strategies will be required over time.
authors.affiliation: Columbia University College of Physicians and Surgeons, 650 W. 168th Street, New York, NY 10032, USA.
authors.forename: Sophie
authors.initials: S
authors.lastname: Hambleton
authors.forename: Anne A
authors.initials: AA
authors.lastname: Gershon
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002644:Chickenpox / Q000517:prevention & control*; D019433:Chickenpox Vaccine / Q000008:administration & dosage* / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D006562:Herpes Zoster / Q000517:prevention & control*; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006801:Humans; D014611:Vaccination
chemical_list: D019433:Chickenpox Vaccine